Search Within

Joachim Yahalom

  1. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (123)
  2. Journal Article (100)
  3. Book Section (17)
  4. Research Letter (4)
  5. Conference Paper (3)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (248)
  2. Radiation Oncology, Department of (248)
  3. Survivorship Research (248)
  4. Department of Medicine (243)
  5. Hematologic Malignancies, Division of (243)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. David Straus (82)
  3. Ariela Noy (71)
  4. Craig Moskowitz (71)
  5. Steven Horwitz (65)
  6. Maria Palomba (63)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (28)
  4. 2022 (11)
  5. 2021 (13)
  6. 2020 (12)

More Years

Publications
  1. Blood (77)
  2. International Journal of Radiation Oncology, Biology, Physics (25)
  3. Hematological Oncology (20)
  4. Journal of Clinical Oncology (16)
  5. Journal of the National Comprehensive Cancer Network (14)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (85)
  2. Elsevier Inc. (40)
  3. Wiley Blackwell (23)
  4. American Society of Clinical Oncology (16)
  5. Harborside Press (14)
  6. Nature Publishing Group (12)

More Publishers

Results (248)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Salvage radiotherapy as a bridge for relapsed secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K. R.; Hajj, C.; Hubbeling, H. G.; Sarkar, R. R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Pike, L. R. G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A phase I study of split‐course bringing radiotherapy (SC‐BRT) prior to commercial CD19 CAR T‐cell therapies for patients with relapsed or refractory B‐cell lymphomas
    Meeting Abstract

    Imber, B. S.; Yahalom, J.; Palomba, M. L.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter experience with radiotherapy for relapse after chimeric antigen receptor T cell therapy in non‐Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H.; Figura, N.; Ladbury, C.; Keit, E. R.; Chew, J.; Fregonese, B.; Silverman, E. A.; Hajj, C.; Shah, G.; Kambhampati, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies
    Meeting Abstract

    Cederquist, G.; Hubbeling, H.; Tringale, K.; Shah, G.; Alarcon Tomas, A.; Shouval, R.; Hajj, C.; Fregonese, B.; Lee, J.; Dahi, P. B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Patterns of disease failure by response to induction therapy in a large cohort of patients with primary central nervous system lymphoma
    Meeting Abstract

    Tringale, K. R.; Yahalom, J.; Scordo, M.; White, C.; Zhang, Z.; Grommes, C.; Imber, B.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Evolving consolidation patterns and modern outcomes for a large longitudinal cohort of primary CNS lymphoma patients
    Meeting Abstract

    Imber, B. S.; Tringale, K.; White, C.; Zhang, Z.; Scordo, M.; Yahalom, J.; Grommes, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Treatment outcomes of limited stage grade 3A follicular lymphoma
    Meeting Abstract

    Sarkar, R. R.; Lee, J.; Zhang, Z.; Zelenetz, A.; Salles, G.; Yahalom, J.; Imber, B.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save